(Q43707358)

English

Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group

scientific article

Statements

Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group (English)
1 August 2001
595-600

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit